Chengchao Xu

3.4k total citations · 2 hit papers
59 papers, 2.4k citations indexed

About

Chengchao Xu is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Cell Biology. According to data from OpenAlex, Chengchao Xu has authored 59 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Public Health, Environmental and Occupational Health and 10 papers in Cell Biology. Recurrent topics in Chengchao Xu's work include Malaria Research and Control (12 papers), Computational Drug Discovery Methods (8 papers) and Endoplasmic Reticulum Stress and Disease (7 papers). Chengchao Xu is often cited by papers focused on Malaria Research and Control (12 papers), Computational Drug Discovery Methods (8 papers) and Endoplasmic Reticulum Stress and Disease (7 papers). Chengchao Xu collaborates with scholars based in China, Singapore and United Kingdom. Chengchao Xu's co-authors include Davis Ng, Jigang Wang, Yin Kwan Wong, Han‐Ming Shen, Chuanbin Yang, Jiang Ting-liang, Youyou Tu, Yingke He, Qingsong Lin and Fulong Liao and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Chengchao Xu

59 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential

2022 121 citations Wei Zhang, Chengchao Xu et al. Acta Pharmaceutica Sinica B profile →
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery

2023 119 citations Chong Qiu, Fei Xia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chengchao Xu China	27	1.2k	266	253	253	246	59	2.4k
Gulam Mustafa Hasan India	29	1.4k 1.1×	137 0.5×	142 0.6×	149 0.6×	87 0.4×	62	3.1k
Xing Du China	22	1.5k 1.2×	166 0.6×	176 0.7×	90 0.4×	109 0.4×	47	2.7k
Antonio Pineda‐Lucena Spain	34	2.3k 1.9×	180 0.7×	223 0.9×	130 0.5×	87 0.4×	127	3.3k
Ian M. Eggleston United Kingdom	31	1.9k 1.6×	254 1.0×	115 0.5×	325 1.3×	172 0.7×	75	3.0k
Joanna E. Burdette United States	36	2.2k 1.8×	454 1.7×	197 0.8×	291 1.2×	525 2.1×	182	4.8k
Kwang Yeon Hwang South Korea	32	2.7k 2.2×	148 0.6×	232 0.9×	200 0.8×	72 0.3×	144	3.7k
Jianbin Zhang China	26	1.3k 1.1×	132 0.5×	200 0.8×	106 0.4×	363 1.5×	56	2.6k
Arun Upadhyay India	23	971 0.8×	113 0.4×	210 0.8×	238 0.9×	44 0.2×	50	1.9k
Julie L. Eiseman United States	34	2.1k 1.7×	302 1.1×	185 0.7×	306 1.2×	89 0.4×	131	3.5k
Jiyoun Lee South Korea	33	1.4k 1.2×	289 1.1×	123 0.5×	155 0.6×	80 0.3×	142	3.3k

Countries citing papers authored by Chengchao Xu

Since Specialization

Citations

This map shows the geographic impact of Chengchao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengchao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengchao Xu more than expected).

Fields of papers citing papers by Chengchao Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengchao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengchao Xu. The network helps show where Chengchao Xu may publish in the future.

Co-authorship network of co-authors of Chengchao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengchao Xu. A scholar is included among the top collaborators of Chengchao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengchao Xu. Chengchao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Shengmao, et al.. (2025). Reviews on the development of digital intelligent fisheries technology in aquaculture. Aquaculture International. 33(3). 8 indexed citations

Wang, Huifang, Runhua Zhou, Chengchao Xu, et al.. (2025). GRP78 Nanobody‐Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy. Advanced Science. 12(19). e2408086–e2408086. 1 indexed citations

Chen, Jiayun, Yunmeng Bai, Wei Xiao, et al.. (2025). The spatiotemporal transcriptional profiling of murine brain during cerebral malaria progression and after artemisinin treatment. Nature Communications. 16(1). 1540–1540. 5 indexed citations

Chen, Jiayun, Qian Zhang, Piao Luo, et al.. (2024). STEP: profiling cellular-specific targets and pathways of bioactive small molecules in tissues via integrating single-cell transcriptomics and chemoproteomics. Chemical Science. 15(12). 4313–4321. 6 indexed citations

Zheng, Liuhai, Huifang Wang, Xueyan Liu, et al.. (2024). A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant. Journal of Medical Virology. 96(3). e29528–e29528. 6 indexed citations

Gao, Peng, Jianyou Wang, Chong Qiu, et al.. (2024). Photoaffinity probe‐based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum. SHILAP Revista de lepidopterología. 3(2). e176–e176. 5 indexed citations

Lyu, Haining, Chunjin Fu, Xin Chai, et al.. (2023). Systematic thermal analysis of the Arabidopsis proteome: Thermal tolerance, organization, and evolution. Cell Systems. 14(10). 883–894.e4. 4 indexed citations

Tang, Huan, Ying Zhang, Tong Yang, et al.. (2023). Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona. Nature Nanotechnology. 18(9). 1067–1077. 91 indexed citations

Gao, Peng, Jiayun Chen, Peng Sun, et al.. (2023). Chemical proteomic profiling with photoaffinity labeling strategy identifies antimalarial targets of artemisinin. Chinese Chemical Letters. 34(12). 108296–108296. 11 indexed citations

10.

Gao, Peng, Jianyou Wang, Jianyou Wang, et al.. (2023). Profiling the Antimalarial Mechanism of Artemisinin by Identifying Crucial Target Proteins. Engineering. 31. 86–97. 11 indexed citations

11.

Zhang, Ying, Yinhua Zhu, Tong Yang, et al.. (2023). How eluents define proteomic fingerprinting of protein corona on nanoparticles. Journal of Colloid and Interface Science. 648. 497–510. 8 indexed citations

12.

Yuan, Haitao, Peng Xia, Xin Sun, et al.. (2022). Photothermal Nanozymatic Nanoparticles Induce Ferroptosis and Apoptosis through Tumor Microenvironment Manipulation for Cancer Therapy. Small. 18(41). e2202161–e2202161. 72 indexed citations

13.

Zhang, Wei, Chengchao Xu, Jichao Sun, et al.. (2022). Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential. Acta Pharmaceutica Sinica B. 12(3). 1019–1040. 121 indexed citations breakdown →

14.

Meng, Yuqing, Jiayun Chen, Yanqing Liu, et al.. (2022). A highly efficient protein corona-based proteomic analysis strategy for the discovery of pharmacodynamic biomarkers. Journal of Pharmaceutical Analysis. 12(6). 879–888. 23 indexed citations

15.

Xia, Peng, Haitao Yuan, Ming Tian, et al.. (2022). Surface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic. Advanced Functional Materials. 33(7). 27 indexed citations

16.

Zhang, Wei, Siyu Xia, Wei Xiao, et al.. (2022). A single-cell transcriptomic landscape of mouse testicular aging. Journal of Advanced Research. 53. 219–234. 49 indexed citations

17.

Wang, Jigang, Jianbin Zhang, Yin Shi, et al.. (2017). Mechanistic Investigation of the Specific Anticancer Property of Artemisinin and Its Combination with Aminolevulinic Acid for Enhanced Anticolorectal Cancer Activity. ACS Central Science. 3(7). 743–750. 82 indexed citations

18.

Zhang, Shan, Chengchao Xu, Katherine E. Larrimore, & Davis Ng. (2017). Slp1-Emp65: A Guardian Factor that Protects Folding Polypeptides from Promiscuous Degradation. Cell. 171(2). 346–357.e12. 45 indexed citations

19.

Xu, Chengchao & Davis Ng. (2015). O-mannosylation: The other glycan player of ER quality control. Seminars in Cell and Developmental Biology. 41. 129–134. 25 indexed citations

20.

Xu, Chengchao, Songyu Wang, Guillaume Thibault, & Davis Ng. (2013). Futile Protein Folding Cycles in the ER Are Terminated by the Unfolded Protein O-Mannosylation Pathway. Science. 340(6135). 978–981. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact